JP2025508912A5 - - Google Patents
Info
- Publication number
- JP2025508912A5 JP2025508912A5 JP2024550866A JP2024550866A JP2025508912A5 JP 2025508912 A5 JP2025508912 A5 JP 2025508912A5 JP 2024550866 A JP2024550866 A JP 2024550866A JP 2024550866 A JP2024550866 A JP 2024550866A JP 2025508912 A5 JP2025508912 A5 JP 2025508912A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- dosage form
- weight
- oral dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22159408 | 2022-03-01 | ||
| EP22159408.8 | 2022-03-01 | ||
| PCT/EP2023/055160 WO2023166045A1 (en) | 2022-03-01 | 2023-03-01 | Pharmaceutical composition comprising diphenyldiazole derivatives and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508912A JP2025508912A (ja) | 2025-04-10 |
| JP2025508912A5 true JP2025508912A5 (https=) | 2026-03-10 |
Family
ID=80623476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024550866A Pending JP2025508912A (ja) | 2022-03-01 | 2023-03-01 | ジフェニルジアゾール誘導体を含む医薬組成物および使用の方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250161273A1 (https=) |
| EP (1) | EP4486340A1 (https=) |
| JP (1) | JP2025508912A (https=) |
| KR (1) | KR20240155237A (https=) |
| CN (1) | CN118715010A (https=) |
| AU (1) | AU2023227368A1 (https=) |
| CA (1) | CA3246018A1 (https=) |
| CL (1) | CL2024002379A1 (https=) |
| IL (1) | IL314952A (https=) |
| MX (1) | MX2024009773A (https=) |
| PE (1) | PE20250781A1 (https=) |
| WO (1) | WO2023166045A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025068949A1 (en) | 2023-09-26 | 2025-04-03 | Teva Pharmaceutical Industries Ltd. | Emrusolmin for use in treating multiple system atrophy |
| KR20250090047A (ko) * | 2023-12-12 | 2025-06-19 | 가천대학교 산학협력단 | 긴 탄소사슬을 포함하는 리파펜틴, 암포테리신 b, 세틸피리디늄, 도미펜, 토코페르솔란을 유효성분으로 포함하는 시누클레인병증 치료용 약제학적 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2687513B1 (en) * | 2008-06-09 | 2020-12-02 | Ludwig-Maximilians-Universität München | Drugs for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
| KR102671166B1 (ko) * | 2015-12-14 | 2024-05-31 | 막스-플랑크-게젤샤프트 츄어 푀르더룽 데어 비쎈샤프텐 에.파우. | 3,5-디페닐-디아졸 화합물의 수용성 유도체 |
-
2023
- 2023-03-01 US US18/840,374 patent/US20250161273A1/en active Pending
- 2023-03-01 PE PE2024001775A patent/PE20250781A1/es unknown
- 2023-03-01 WO PCT/EP2023/055160 patent/WO2023166045A1/en not_active Ceased
- 2023-03-01 KR KR1020247029979A patent/KR20240155237A/ko active Pending
- 2023-03-01 JP JP2024550866A patent/JP2025508912A/ja active Pending
- 2023-03-01 CN CN202380024479.XA patent/CN118715010A/zh active Pending
- 2023-03-01 EP EP23707119.6A patent/EP4486340A1/en active Pending
- 2023-03-01 CA CA3246018A patent/CA3246018A1/en active Pending
- 2023-03-01 MX MX2024009773A patent/MX2024009773A/es unknown
- 2023-03-01 AU AU2023227368A patent/AU2023227368A1/en active Pending
- 2023-03-01 IL IL314952A patent/IL314952A/en unknown
-
2024
- 2024-08-08 CL CL2024002379A patent/CL2024002379A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2131428C1 (ru) | Рисперидонпамоат, способ его получения, антипсихотическая композиция на его основе и способ ее получения | |
| JP2025508912A5 (https=) | ||
| CN1235547A (zh) | 用于局部给药工具的含有无环鸟苷的抗疱疹药物组合物 | |
| KR960004345A (ko) | 2-(2- 아미노-1,6- 디하이드로-6- 옥소-퓨린-9-일)메톡시-1,3- 프로판 디올 유도체 | |
| ES2897024T3 (es) | Composiciones que comprenden agonistas del receptor de PGI2 y procesos para la preparación de las mismas | |
| JP2010509204A5 (https=) | ||
| US9012509B2 (en) | Method of treating non-alcoholic steatohepatitis | |
| KR20170061616A (ko) | 피마살탄의 신규 염 | |
| JP2013139469A (ja) | 二環式化合物を含む医薬組成物およびその二環式化合物の安定化方法 | |
| EP4126057B1 (en) | Composition having improved voluntary acceptance | |
| RU2017137960A (ru) | Применение тиаоксосоединений для уменьшения содержания аро сз | |
| EP0303232B1 (en) | Use of benzylpyridine derivatives in the manufacture of a medicament for the treatment of dementia | |
| JPS58206524A (ja) | 抗腫瘍剤 | |
| US9358217B2 (en) | Methods for reducing triglyceride, total cholesterol and low density lipoprotein blood levels | |
| CN112755196B (zh) | 多奈哌齐离子液体 | |
| US20220033355A1 (en) | Crystal form a of 2-(2, 5-dioxopyrrolidin-1yl) ethyl methyl fumarate, preparation method therefor and use thereof | |
| JP2024522030A (ja) | フェノキシアルキルカルボン酸誘導体、およびトリグリセリドレベルを低下させることにおけるその使用 | |
| JPH07267875A (ja) | オーレオバシジン類の高濃度溶液製剤 | |
| CN104546875A (zh) | 三萜皂苷衍生物及其医药用途 | |
| KR830000677A (ko) | 물질의 조성물 | |
| JPS58208224A (ja) | 抗腫瘍剤 | |
| JPS58206521A (ja) | 抗腫瘍剤 |